Pamela Ruiz, PA
Physician Assistant · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 2 carriers
- Office
- 1
Offices
1 location · Patricia Sitnitsky PC · 11 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
7 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Pamela Ruiz’s office at (408) 495-5770 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$4,506
Medicare paid this office $4,506 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 13 | $1,349 | $96 |
| Short return visit (20+ min) | 17 | $1,275 | $75 |
| Assessment of emotional or behavioral problems | 15 | $80 | $5 |
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 74 · Health risk score 0.99. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 36%.
The office billed $12,369, Medicare allowed $5,426 and paid $4,506; for 66 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Money from drug and device companies
$2,022 in 2025
| 2025 | 18 | 76 | None | $2,022 |
| 2024 | 4 | 9 | None | $306 |
| 2023 | 10 | 21 | None | $585 |
| 2022 | 15 | 82 | $119 | $1,640 |
| 2021 | 18 | 79 | None | $2,044 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $444 | 17 payments
|
| Lundbeck | Vyepti | $346 | 9 payments
|
| Lilly USA | Kisunla | $239 | 8 payments
|
| ViiV Healthcare | Apretude | $195 | 8 payments
|
| Pfizer | Eliquis | $172 | 9 payments
|
| Exact Sciences | The Cologuard Plus Collection Kit | $125 | 5 payments
|
See all 76 published payments
| Exact Sciences | Meals · 2025-12-19 | None | $27 |
| Pfizer | Meals · 2025-12-16 | Eliquis | $24 |
| Lundbeck | Meals · 2025-12-04 | Vyepti | $27 |
| Novo Nordisk | Meals · 2025-11-20 | Rybelsus | $10 |
| Axsome Therapeutics | Meals · 2025-11-12 | Symbravo | $28 |
| Exact Sciences | Meals · 2025-11-05 | The Cologuard Plus Collection Kit | $23 |
| Currax Pharmaceuticals | Meals · 2025-10-30 | Contrave | $15 |
| Lundbeck | Meals · 2025-10-29 | Vyepti | $28 |
| Novo Nordisk | Meals · 2025-10-17 | Wegovy | $33 |
| Abbvie | Meals · 2025-10-15 | Ubrelvy | $29 |
| Edwards Lifesciences | Meals · 2025-10-15 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $42 |
| Lilly USA | Meals · 2025-10-09 | Mounjaro | $9 |
| Lilly USA | Meals · 2025-10-09 | Kisunla | $119 |
| Phadia US | Meals · 2025-10-07 | Immunocap | $17 |
| Novo Nordisk | Meals · 2025-09-18 | Rybelsus | $24 |
| Novo Nordisk | Meals · 2025-09-12 | Rybelsus | $7 |
| ViiV Healthcare | Meals · 2025-09-04 | Apretude | $15 |
| Gilead Sciences | Meals · 2025-09-04 | None | $26 |
| Lilly USA | Meals · 2025-08-13 | Kisunla | $18 |
| Novo Nordisk | Meals · 2025-08-13 | None | $22 |
| Lilly USA | Meals · 2025-08-06 | Mounjaro | $7 |
| ViiV Healthcare | Meals · 2025-08-06 | Apretude | $5 |
| ViiV Healthcare | Meals · 2025-08-06 | Apretude | $14 |
| Astellas Pharma US | Meals · 2025-07-31 | Veozah | $33 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-31 | Caplyta | $29 |
| Pfizer | Meals · 2025-07-25 | Nurtec Odt | $7 |
| Abbvie | Meals · 2025-07-24 | Botox | $30 |
| Axsome Therapeutics | Meals · 2025-07-24 | Symbravo | $28 |
| Novo Nordisk | Meals · 2025-07-15 | Ozempic | $34 |
| Novo Nordisk | Meals · 2025-07-15 | Wegovy | $10 |
| Lundbeck | Meals · 2025-07-11 | Rexulti | $30 |
| Lilly USA | Meals · 2025-07-08 | Kisunla | $24 |
| Pfizer | Meals · 2025-07-02 | Nurtec Odt | $18 |
| ViiV Healthcare | Meals · 2025-07-01 | Apretude | $21 |
| ViiV Healthcare | Meals · 2025-07-01 | Apretude | $7 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-01 | Xifaxan | $19 |
| Novo Nordisk | Meals · 2025-06-26 | Wegovy | $27 |
| Pfizer | Meals · 2025-06-24 | Nurtec Odt | $6 |
| Lilly USA | Meals · 2025-06-19 | Mounjaro | $20 |
| Lundbeck | Meals · 2025-06-17 | Vyepti | $27 |
| Pfizer | Meals · 2025-06-12 | Eliquis | $25 |
| Exact Sciences | Meals · 2025-06-12 | The Cologuard Plus Collection Kit | $27 |
| GlaxoSmithKline | Meals · 2025-06-05 | Trelegy Ellipta | $31 |
| Novo Nordisk | Meals · 2025-05-28 | Ozempic | $8 |
| Novo Nordisk | Meals · 2025-05-28 | Wegovy | $7 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-19 | Xifaxan | $25 |
| Lilly USA | Meals · 2025-05-15 | Kisunla | $24 |
| ViiV Healthcare | Meals · 2025-05-14 | Apretude | $122 |
| Pfizer | Meals · 2025-05-14 | Nurtec Odt | $19 |
| Lundbeck | Meals · 2025-05-14 | Rexulti | $29 |
| Currax Pharmaceuticals | Meals · 2025-05-07 | Contrave | $16 |
| Novo Nordisk | Meals · 2025-04-29 | Wegovy | $30 |
| Gilead Sciences | Meals · 2025-04-25 | None | $25 |
| Novo Nordisk | Meals · 2025-04-23 | Ozempic | $26 |
| Exact Sciences | Meals · 2025-04-23 | The Cologuard Plus Collection Kit | $26 |
| Lilly USA | Meals · 2025-04-10 | Mounjaro | $18 |
| Novo Nordisk | Meals · 2025-04-09 | Ozempic | $30 |
| Merck Sharp & Dohme | Meals · 2025-04-08 | Gardasil 9 | $15 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-04-07 | Xifaxan | $21 |
| Novo Nordisk | Meals · 2025-04-01 | Ozempic | $125 |
| Novo Nordisk | Meals · 2025-03-27 | Ozempic | $10 |
| Pfizer | Meals · 2025-03-27 | Eliquis | $26 |
| Lundbeck | Meals · 2025-03-26 | Vyepti | $28 |
| Lundbeck | Meals · 2025-03-21 | Rexulti | $24 |
| Novo Nordisk | Meals · 2025-03-19 | Ozempic | $32 |
| Abbvie | Meals · 2025-03-06 | Ubrelvy | $33 |
| Exact Sciences | Meals · 2025-03-04 | Cologuard Collection Kit | $22 |
| Pfizer | Meals · 2025-02-27 | Paxlovid | $23 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-19 | Xifaxan | $22 |
| Novo Nordisk | Meals · 2025-02-14 | Ozempic | $8 |
| Pfizer | Meals · 2025-02-12 | Eliquis | $25 |
| ViiV Healthcare | Meals · 2025-02-10 | Apretude | $1 |
| ViiV Healthcare | Meals · 2025-02-10 | Apretude | $10 |
| Amgen | Meals · 2025-01-23 | Tavneos | $17 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $29 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $125 |
See earlier years (2024, 2023, 2022, 2021)
2024: $306
| ViiV Healthcare | Apretude | $174 | 3 payments
|
| Abbvie | Botox | $51 | 2 payments
|
| Lilly USA | Jardiance | $44 | 2 payments
|
| Novo Nordisk | Ozempic | $37 | 2 payments
|
2023: $585
| Novo Nordisk | Wegovy | $229 | 8 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $124 | 2 payments
|
| Abbvie | Viberzi | $64 | 3 payments
|
| Lilly USA | Mounjaro | $44 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $26 | 1 payment
|
| Pfizer | Comirnaty | $22 | 1 payment
|
| Supernus Pharmaceuticals | Tlando | $21 | 1 payment
|
| Antares Pharma | Nocdurna | $20 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $19 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $15 | 1 payment
|
2022: $1,640
| Novo Nordisk | Rybelsus | $399 | 26 payments
|
| Abbvie | Creon | $244 | 16 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $166 | 7 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $159 | 7 payments
|
| Lilly USA | Mounjaro | $139 | 6 payments
|
| EPI Health | Wynzora | $119 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $98 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $71 | 4 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $64 | 3 payments
|
| Merck Sharp & Dohme | Belsomra | $46 | 2 payments
|
| Amarin Pharma | Vascepa | $46 | 2 payments
|
| Iti | Caplyta | $31 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $22 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $20 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $16 | 1 payment
|
2021: $2,044
| Novo Nordisk | Ozempic | $560 | 25 payments
|
| AbbVie | Vraylar | $336 | 12 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $211 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $189 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $178 | 3 payments
|
| Amarin Pharma | Vascepa | $117 | 9 payments
|
| Becton Dickinson and | Bd Nano | $95 | 3 payments
|
| Iti | Caplyta | $65 | 3 payments
|
| Merck Sharp & Dohme | Belsomra | $58 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $44 | 2 payments
|
| Lilly USA | Jardiance | $41 | 2 payments
|
| Corcept Therapeutics | Korlym | $32 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $26 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $24 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Pfs | $20 | 1 payment
|
| Pfizer | Eliquis | $20 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $14 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $14 | 1 payment
|
Professional record
- NPI
- 1760078976
- Licence
- CA PA59360
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 827 Altos Oaks Dr Ste 4, Los Altos, CA, 94024
- NPI first listed
- 2020-12-12
- NPI last updated
- 2025-05-29
- NPI record certified
- 2025-05-29
This is when the NPI record was last certified, not a medical board exam.